Significant mitral regurgitation worsens the prognosis and favors the decision of conservative treatment in octogenarians with severe symptomatic aortic stenosis

Eur J Intern Med. 2018 Sep:55:40-46. doi: 10.1016/j.ejim.2018.05.018. Epub 2018 May 31.

Abstract

Introduction: The coexistence of significant mitral regurgitation (MR) and severe aortic stenosis is prevalent, has a prognostic impact and makes treatment in the elderly population a complex issue. The aim of this study is to determine the prevalence of significant MR among a population of octogenarians and its influence on treatment and prognosis.

Methods: We used the data from PEGASO (Pronóstico de la Estenosis Grave Aórtica Sintomática del Octogenario), a prospective registry that consecutively included 928 patients aged ≥80 years with severe symptomatic aortic stenosis.

Results: The prevalence of significant MR was 8.5% (79 patients) and independently associated with the decision to treat conservatively (odds ratio = 2.28, 95% confidence interval: 1.31-3.95, p = 0.003). The group of patients with significant MR had higher overall mortality at 12 months follow-up (51.9% vs 25%, p < 0.001), which remained on division into subgroups based on the presence of comorbidities (Charlson<5: 49.2% vs 21.9%, p < 0.001; and Charlson ≥5: 62.5% vs 41.7%, p = 0.07). Within the group of patients in whom conservative treatment was performed, those with significant MR had higher mortality at one year (62.7% vs 35%, p < 0.001). MR was a significant independent predictor of overall mortality at 12-month follow-up (hazard ratio = 1.87, 95% confidence interval: 1.09-3.18, p = 0.022).

Conclusions: Significant MR has a high prevalence and worsens the prognosis of octogenarian patients with severe symptomatic aortic stenosis, especially in patients with conservative treatment, independently of the existence of comorbidities.

Keywords: Aortic stenosis; Aortic surgery; Mitral regurgitation; Octogenarian; Prognosis; Transcatheter aortic valve implantation.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged, 80 and over
  • Aortic Valve Stenosis / mortality*
  • Aortic Valve Stenosis / therapy
  • Comorbidity
  • Conservative Treatment*
  • Female
  • Heart Valve Prosthesis Implantation / adverse effects
  • Humans
  • Male
  • Mitral Valve Insufficiency / complications*
  • Multivariate Analysis
  • Prognosis
  • Prospective Studies
  • Registries
  • Severity of Illness Index
  • Spain
  • Survival Analysis